NEW YORK, April 26, 2017 -- Wolf Haldenstein Adler Freeman & Herz LLP announces a class action has been filed in the United States District Court for the Southern District of New York against Celadon Group, Inc. ("Celadon" or the "Company") (NYSE:CGI) on behalf of investors who purchased or otherwise acquired Celadon common stock between December 30, 2016 and April 18, 2017, inclusive (the "Class Period”).
Investors who have incurred losses in shares of Celadon Group, Inc. are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.
If you suffered a loss in Celadon Group, Inc. shares and would like to assist with the litigation process as a lead plaintiff, you may, no later than June 19, 2017, request that the Court appoint you lead plaintiff of the proposed class.
On December 30, 2016, Celadon announced the closing of a Joint Venture agreement with Element Transportation LLC ("Element").
The filed class action complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:
- Celadon's equity contribution to its Joint Venture with Element was $68.2 million, rather than the $100 million contribution the Company reported in its Securities and Exchange Commission (“SEC”) filings;
- the Company was being actively investigated by the SEC; and
- that as a result of the foregoing, Celadon's publicly disseminated financial statements were materially false and misleading.
The complaint alleges that on April 5, 2017 a report issued by Prescience Point Research Group ("Prescience Point") accused Celadon of using "off-balance sheet entities . . . and manipulative accounting practices to hide its insolvent condition from investors and creditors." Specifically, the Prescience Point report alleges that Element owed Celadon $31.8 million and that pursuant to the Joint Venture agreement, Element gave Celadon $31.8 million, which Celadon then handed right back to Element with the Joint Venture as the intermediary.
On that trading day, Celadon's stock price declined by 13.6% to close at $5.40 per share.
On April 19, 2017, Prescience Point published another report stating that Prescience Point was denied information about Celadon sought under the Freedom of Information Act ("FOIA") due to an ongoing SEC investigation. Celadon's stock price further declined by 4.5% to close at $4.20 per share.
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.
## Follow the firm and learn about newly filed cases on Twitter and Facebook. ##
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.
Contact: Wolf Haldenstein Adler Freeman & Herz LLP Kevin Cooper, Esq. Gregory Stone, Director of Case and Financial Analysis Email: [email protected], [email protected] or [email protected] Tel: (800) 575-0735 or (212) 545-4774


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Samsung Electronics Shares Jump on HBM4 Mass Production Report
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



